NCT00785811

Effect of Chronic Supplementation of L-arginine in the Muscular Performance

Randomized, Double Blind, Placebo Controlled Study of Parallel Groups to Evaluate the Effect of Chronic Supplementation of L-arginine in the Muscular Performance.

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Sanofi · Industry
• Sex: All
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The primary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular fatigue of the quadriceps, expressed in terms of the Fatigue Resistance Factor (FRF). The secondary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular force the quadriceps.

Conditions

• Muscular Fatigue

Interventions

Type	Name	Description
DRUG	L-arginine aspartate (Targifor)	3g of L-arginine taken orally in a single daily dose for 8 weeks
DRUG	Placebo L-arginine aspartate (Targifor)	Placebo of L-arginine taken orally in a single daily dose for 8 weeks

Timeline

• Start date: 2008-10-01
• Primary completion: 2008-12-01
• Completion: 2008-12-01
• First posted: 2008-11-05
• Last updated: 2011-03-16

Locations

1 site across 1 country: Brazil